In vivo experiments showed no abnormalities in liver or kidney function, and local intraocular injection reduced systemic toxicity, indicating its translational medicine potential
Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial
Standard GLP-1 dosing follows the FDA-approved titration schedule for each compound typically reaching maintenance doses within weeks
No reliable human adverse-effect profile exists because adequate clinical safety studies and systematic surveillance are absent
Rouhanipour H, Sharifi SD, Irajian GH, Jalal MP
How This Applies to Popular Research Peptides For broad injectable-peptide research, the 28-day refrigerator rule is a useful starting point